The Cell Medica Approach

Cell Medica is committed to transforming the lives of patients with cancer by developing the therapeutic potential of off-the-shelf engineered NKT cell therapies.

Our current focus endeavors to harness the natural biology of a specific subset of cytotoxic T cells, called Natural Killer T cells (NKT cells).